AARTI DRUGS LTD. - 524348 - Update on board meeting
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2020 ,inter alia, to consider and approve Update on board meeting20-10-2020
20-10-2020
AARTI DRUGS LTD. - 524348 - Compliance Of Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended September 30, 2020
We are forwarding herewith Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from Jagdish Patel & Co., Practicing Company Secretary, for the half year ended September 30, 2020 for your perusal and record.17-10-2020
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates17-10-2020
AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Board Meeting
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2020 ,inter alia, to consider and approve This is to inform you that next Board Meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 23, 2020 to consider, approve and take on record Audited Financial Results for the Quarter and Half year ended September 30, 2020.17-10-2020
AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclose herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company.17-10-2020
AARTI DRUGS LTD. - 524348 - Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201514-10-2020
AARTI DRUGS LTD. - 524348 - Shareholding for the Period Ended September 30, 2020
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here13-10-2020
AARTI DRUGS LTD. - 524348 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- RUSHIKESH V DEOLEDesignation :- Company Secretary and Compliance Officer13-10-2020
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates08-10-2020
AARTI DRUGS LTD. - 524348 - Clarification
With reference to Movement in Price, Aarti Drugs Ltd has submitted to BSE a copy of Clarification is enclosed.07-10-2020